Willem Overwijk is a tenured professor in the Departments of Melanoma Medical Oncology and Immunology at MD Anderson Cancer Center in Houston, Texas. The mission of his Cancer Immunotherapy Laboratory is to understand the interplay between cancer and the immune system and to translate this understanding into new immune-based therapies for patients with cancer.
Dr. Overwijk is an associate editor of the Journal for Immunotherapy of Cancer and a board member of the International Society for Immunotherapy of Cancer. He has received awards for his teaching, faculty achievement, and bench-to-bedside research.
Dr. Overwijk trained at the Surgery Branch of the National Cancer Institute in Bethesda, Maryland, and received his doctorate in biochemistry and molecular biology from the George Washington University in Washington, DC.
Education & Training
- 1994: Combined College and Graduate School of the University of Utrecht, Utrecht, USA, BS/MS, Medical Biology Tumor Immunology
- 2000: The George Washington University, Washington, USA, PHD, Biochemistry and Molecular Biology
- 2001-2004: Post-doctoral fellowship, Department of Immunology, Tumor Immunology, The Netherlands Cancer Institute, Dept. of Immunology, Amsterdam
Awards & Honors
- 2013: Emil Frei III Award for Excellence in Translational Research 2013, The University of Texas MD Anderson Cancer Center